New Zealand markets closed

Vizsla Silver Corp. (VZLA)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.1000+0.0700 (+6.80%)
At close: 03:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 187.54M
Enterprise value 179.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.65
Enterprise value/revenue N/A
Enterprise value/EBITDA -9.54

Trading information

Stock price history

Beta (5Y monthly) 2.27
52-week change 3-54.86%
S&P500 52-week change 3-13.53%
52-week high 32.3900
52-week low 30.9100
50-day moving average 31.1540
200-day moving average 31.4139

Share statistics

Avg vol (3-month) 3132.5k
Avg vol (10-day) 3160.29k
Shares outstanding 5178.68M
Implied shares outstanding 6N/A
Float 8139.15M
% held by insiders 111.40%
% held by institutions 117.90%
Shares short (14 Nov 2022) 4530.93k
Short ratio (14 Nov 2022) 44.21
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.30%
Shares short (prior month 13 Oct 2022) 4358.07k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 29 Apr 2022
Most-recent quarter (mrq)30 Jul 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-8.63%
Return on equity (ttm)-10.37%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -18.59M
Net income avi to common (ttm)-13.51M
Diluted EPS (ttm)-0.1240
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.11M
Total cash per share (mrq)0.07
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.13
Book value per share (mrq)0.99

Cash flow statement

Operating cash flow (ttm)-17.13M
Levered free cash flow (ttm)-59.28M